Glucagon-like peptide-1 cleavage product improves cognitive function in a mouse model of down syndrome

Neuroscience

• Cognitive Function 100%
• Glucagon-Like Peptide-1 100%
• Down Syndrome 100%
• Cognitive Disorders 30%
• Glucose 20%
• Oxidative Stress 20%
• Neuroprotection 10%
• Neurodegenerative Disorder 10%
• Hippocampus 10%
• Glucagon-Like Peptide 1 Receptor 10%
• Insulin 10%
• Dendritic Spine 10%
• Neuronal Plasticity 10%
• Incretin 10%
• Binding Affinity 10%
• Long-Term Potentiation 10%
• Chromosome 21 10%
• Alzheimer's Disease 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Mouse Model 100%
• Glucagon-Like Peptide-1 100%
• Down Syndrome 100%
• Cognitive Defect 30%
• Glucose 20%
• Human 10%
• Wild Type Mouse 10%
• Potentiation 10%
• Neuroprotection 10%
• Systemic Administration 10%
• Intellectual Impairment 10%
• Glucagon-Like Peptide 1 Receptor 10%
• Trisomy 21 10%
• Degenerative Disease 10%
• Alzheimer's Disease 10%
• Insulin 10%
• Incretin 10%